14 January 2004

                                  Jourdan plc                                  

                                Trading Update                                 

The Board of Jourdan plc ("Jourdan" or the "Group"), whose operating companies
include Suncrest, Westfield Medical, Nelsons Labels and Corby, announce that
although trading conditions remain challenging, particularly at Nelsons Labels
and Corby, the Group's results for the six months to 31 December 2003 are
expected to show a significant improvement over market expectations.

At the time of Jourdan's results for the 12 months ended 30 June 2003, the
Chairman, David Abell, stated that there were mildly encouraging signs of
momentum across the Group.  This trend has continued throughout the first half,
which is by far the Group's stronger trading period.  Progress at Suncrest and
Westfield Medical, the two largest and most important companies in the Group,
has been particularly strong.  As a result the board anticipates that turnover
of the continuing businesses for the six months to 31 December 2003 will be not
less than �14.1m (2002: �12.6m) and profit before tax, goodwill and investment
provisions will be not less than �1.0m, compared to �0.3m for the equivalent
period last year.

Results for the six months to 31 December 2003 are expected to be announced in
the second half of February 2004.

Enquiries:

David Abell                   01476 403 456
                                           
Chairman                                   
                                           
Jourdan plc                                
                                           
Russell Cook                  020 7739 8200
                                           
Charles Stanley & Co. Limited              
                                           



END